0001437749-21-013628.txt : 20210528 0001437749-21-013628.hdr.sgml : 20210528 20210528083135 ACCESSION NUMBER: 0001437749-21-013628 CONFORMED SUBMISSION TYPE: 5/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aubrey de Lavenu Harold Andre CENTRAL INDEX KEY: 0001737899 FILING VALUES: FORM TYPE: 5/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 21976291 MAIL ADDRESS: STREET 1: APT 627 VALE DO LOBO CITY: ALMANCIL STATE: S1 ZIP: 8135-034 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 5/A 1 rdgdoc.xml FORM 5/A X0306 5/A 2017-12-31 2021-04-26 0 1 0001653821 CEN BIOTECH INC CENBF 0001737899 Aubrey de Lavenu Harold Andre 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 Common Stock 2017-11-30 4 A 0 L 20000 0 A 689571 D 20,000 shares of common stock of issuer were granted by the issuer on November 30, 2017, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors. 689,571 shares were beneficially owned by the reporting person of which 656,250 shares were issuable upon conversion of convertible notes held by the reporting person at 12/31/2017. The reporting person has served as a member of the board of directors of the issuer since July 2017 and was appointed to serve as a vice president of the issuer on April 2, 2021. /s/ Harold Aubrey de Lavenu 2021-05-28